XFOR: X4 Pharmaceuticals, Inc Sotuvga nisbatan narx
X4 Pharmaceuticals (XFOR) immunologik agentlarni ishlab chiqishga ESG prinsiplari va bioetikani integratsiya qiladi. Kompaniyaning P/S koeffitsiyenti daromadning bozor qiymatini vizuallashtiradi, bunda 18.70 eng so'nggi darajani ifodalaydi. Korporativ texnologik gigantlar tomonidan bosim o'tkazish xavfiga qaramay, biznes noyob kasalliklar nishasida monopoliya salohiyatini saqlab qolmoqda va ixtisoslashgan ekspertlarni faol jalb qilish orqali o'zining R&D yadrosini mustahkamlamoqda.
XFOR (X4 Pharma): tahliliy kesimlar va indikatorlar boʻyicha maʼlumotlar
- aksiya narxi va konsensus maqsadli narx:
- bozor kapitallashuvi haqida ma'lumot:
- aksiyadorlik kapitalining balans qiymati ma'lumotlari:
- biznesning qarz tarkibi va likvidligi tafsilotlari:
Qarzning xususiy kapitalga nisbati X4 Pharmaceuticals|XFOR - Uzoq muddatli majburiyatlarning o'z kapitaliga nisbati|Qisqa muddatli qarzning kapitalga nisbati X4 Pharmaceuticals, Inc|XFOR - Jamlangan qarz majburiyatlari|Balans kapitallashuviga qarzlar X4 Pharma|XFOR - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli qarzi X4 Pharmaceuticals|Tezkor likvidlik x4pharma.com
- sof daromad va qiymat multiplikatorlari ko'rsatkichlari:
XFOR - Sof daromad|Prognoz qilingan kelajakdagi foyda X4 Pharmaceuticals|XFOR - P/E multiplikatori|Forvard P/E multiplikatori X4 Pharmaceuticals Inc.|XFOR - Narx-foyda va o‘sish multiplikatori|EV/EBITDA multiplikatori X4 Pharma|XFOR - Foizlar, soliqlar va eskirishdan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun sof foyda X4 Pharmaceuticals|XFOR - Bir aksiya uchun sof foyda (EPS TTM)|So'nggi 12 oy davomida bir aksiya uchun sof foydaning yillik o'sishi x4pharma.com|XFOR - Joriy yil uchun bitta aksiya uchun sof foyda o'sishi|Keyingi yil uchun foyda o'sishi prognozi X4 Pharmaceuticals
- sotuvlar va tushum bo'yicha ma'lumotlar:
Kompaniyaning asosiy tahlili:XFOR x4pharma.com
Investorlar bozor kapitalizatsiyasining yillik daromadga nisbatini hisobga olgan holda fundamental qiymat drayverlarini aniqlashlari kerak. Ushbu koeffitsient bozor sotuvlarning bir birligi uchun to'lashga tayyor bo'lgan premiumni o'lchaydi va kompaniyaning normallashtirilgan P/S ko'rsatkichini vizuallashtiradi. Ushbu indikatorning tendentsiyasi biznes samaradorligiga oid kutishlarni aks ettiradi. X4 Pharmaceuticals (XFOR) uchun bunday baholash barqaror immunologik dori ishlab chiqarishdagi innovatsiyalarning kapitalizatsiyasini va bioetikaga qat'iy rioya qilinishini tasdiqlaydi.
Raqobatdosh kompaniyalar
argenx.com - Kapitalizatsiya va daromad nisbati|P/S multiplikatori BNTX (BioNTech)|Abivax Pharma (ABVX) - Sotuvga nisbatan narx|ADMA: Kapitalizatsiyaning daromadga nisbati|PTGX (Protagonist Corp) - Kapitalizatsiya va daromad nisbati|Kapitalizatsiya va daromad nisbati Immunovant, Inc.|Kapitalizatsiyaning daromadga nisbati kiniksa.com|GRFS - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati ADPT|CLDX - Narxning sotuvga nisbati|P/S multiplikatori Aurinia Corp (AUPH)|Bozor kapitallashuvining daromadga nisbati BioCryst|P/S multiplikatori veratx.com VERA|Dianthus Therapeutics, Inc. - P/S multiplikatori|PHVS: Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati AbCellera Biologics Inc ABCL|TRML (Tourmaline) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati PGEN|P/S multiplikatori pharming.com|P/S multiplikatori NKTR|P/S multiplikatori Upstream Bio, Inc. (UPB)|Zenas Biopharma, Inc. - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori Immunome Bio IMNM|GOSS (Gossamer Bio, Inc.) - Sotuvga nisbatan narx|kalvista.com (KALV) - Kapitalizatsiyaning daromadga nisbati|SEPN: P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Pieris Pharma|Savara Corp (SVRA) - Kapitalizatsiyaning sotish hajmiga nisbati|P/S multiplikatori Rigel Corp|ANAB (AnaptysBio, Inc.) - Narx/daromad koeffitsiyenti|P/S multiplikatori astriatx.com (ATXS)|enGene - Kapitalizatsiyaning daromadga nisbati|P/S multiplikatori RAPT Therapeutics Inc. RAPT|Aerovate - P/S multiplikatori|ACRS: Narxning daromadga nisbati|Kyverna Therapeutics (KYTX) - Narxning daromadga nisbati|TLSA (tizianalifesciences.com) - Narxning daromadga nisbati|CABA: Narx/daromad koeffitsiyenti|Kapitalizatsiyaning daromadga nisbati Ventyx Biosciences Inc. (VTYX)|Kapitalizatsiya va daromad nisbati Theratechnologies Inc THTX|P/S multiplikatori Avalo Therapeutics Inc (AVTX)|Eledon Pharmaceuticals (ELDN) - Narxning sotuvga nisbati|agenusbio.com - Narxning daromadga nisbati|CLYM (Climb Bio) - Sotuvga nisbatan narx|ZURA: Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati aTyr ATYR|ADAG (Adagene Inc.) - Narxning daromadga nisbati|Narxning sotuvga nisbati ImageneBio IMA|P/S multiplikatori Shattuck Therapeutics|Equillium, Inc. (EQ) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori connectbiopharm.com (CNTB)|P/S multiplikatori IMUX (Immunic)|Atara Biotherapeutics, Inc. - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati InflaRx GmbH (IFRX)|ACET: Narxning daromadga nisbati|CELU (celularity.com) - Kapitalizatsiyaning daromadga nisbati|INmune Bio Inc (INMB) - P/S multiplikatori|BRNS (Barinthus Bio) - P/S multiplikatori|Kapitalizatsiyaning daromadga nisbati Kezar Life Sciences Inc (KZR)|SAB Biotherapeutics (SABS) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori akaritx.com (AKTX)|Narx/daromad koeffitsiyenti ENLV|Q32 Bio Inc - Narxning daromadga nisbati|GOVX: Kapitalizatsiyaning daromadga nisbati|EDSA: Narxning daromadga nisbati|IBIO (iBio, Inc.) - Kapitalizatsiyaning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati Carisma Therapeutics Inc.|XTLB (XTL Biopharmaceuticals Ltd.) - P/S multiplikatori|Narxning daromadga nisbati BOLT|Kapitalizatsiya va daromad nisbati HCW Biologics Inc. HCWB|P/S multiplikatori aptevotherapeutics.com (APVO)|AIM: Sotuvga nisbatan narx|ADTX - Kapitalizatsiyaning daromadga nisbati|GRI Bio (GRI) - Kapitalizatsiya va daromad nisbati|XRTX (XORTX Therapeutics Inc) - Kapitalizatsiya va daromad nisbati|HIND (ReShape Lifesciences) - Kapitalizatsiyaning daromadga nisbati|Revelation Biosciences Corp - Bozor kapitallashuvining daromadga nisbati|Narxning daromadga nisbati Indaptus Therapeutics|scinai.com - Narxning sotuvga nisbati|P/S multiplikatori CALI|AFMD (affimed.com) - Bozor kapitallashuvining daromadga nisbati|P/S multiplikatori ALLK (Allakos)|P/S multiplikatori HOOKIPA Pharma, Inc. HOOK|IGMS - Narxning daromadga nisbati|Bozor kapitallashuvining daromadga nisbati ITOS (iteostherapeutics.com)|Ocean Biomedical (OCEA) - Narxning daromadga nisbati|Kapitalizatsiyaning daromadga nisbati TC BioPharm (Holdings) Plc|THRD (Third Harmonic Bio, Inc) - P/S multiplikatori
